Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
11/17/2004 | EP1477185A2 Pneumococcal genes, portions thereof, expression products therefrom and uses of such genes, portions and products |
11/17/2004 | EP1477184A2 Neospora vaccine |
11/17/2004 | EP1477175A1 Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient |
11/17/2004 | EP1477172A1 Treatment of shipping fever |
11/17/2004 | EP1476752A1 Method for diagnosing and monitoring hemostatic dysfunction, severe infection and systematic inflammatory response syndrome |
11/17/2004 | EP1476582A1 Nucleotide sequence coding for a tolc containing a heterologous amino acid sequence |
11/17/2004 | EP1476581A2 Recombinant bovine immunodeficiency virus based gene transfer system |
11/17/2004 | EP1476574A2 RNA INTERFERENCE MEDIATED INHIBITION OF TYPE 1 INSULIN-LIKE GROWTH FACTOR RECEPTOR (IGF-1R) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
11/17/2004 | EP1476564A1 Cooperative oligonucleotides |
11/17/2004 | EP1476543A1 Viral variants with altered susceptibility to nucleoside analogs and uses thereof |
11/17/2004 | EP1476541A2 Novel cytokine zcytor17 ligand |
11/17/2004 | EP1476540A1 Methods for producing gama delta t cells |
11/17/2004 | EP1476470A1 Starch derivatives, starch active substance conjugates, method for the production thereof and their use as medicaments |
11/17/2004 | EP1476468A2 Human monoclonal antibody fab fragments directed against hcv e2 glycoprotein and endowed with in vitro neutralizing activity |
11/17/2004 | EP1476467A1 Immunoglobulin igg3 as a marker for protecting against infectious viral diseases, and the uses of the same |
11/17/2004 | EP1476465A1 Method for producing interferon |
11/17/2004 | EP1476461A2 Immune-modulating peptide made of s. aureus enterotoxin b |
11/17/2004 | EP1476458A2 Rna interference mediated inhibition of platelet derived growth factor (pdgf) and platelet derived growth factor receptor (pdgfr) gene expression using short interfering nucleic acid (sina) |
11/17/2004 | EP1476456A2 Compositions and methods for surrogate antibody modulation of an immune response and transport |
11/17/2004 | EP1476454A1 Binding epitopes for helicobacter pylori and use thereof |
11/17/2004 | EP1476438A1 Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |
11/17/2004 | EP1476434A2 Pyridazine derivatives, use of the same as medicaments, pharmaceutical compositions and method for producing the same |
11/17/2004 | EP1476432A1 Therapeutic substituted indazole derivatives |
11/17/2004 | EP1476425A2 Heterocyclic arylsulfonamidobenzylic compounds |
11/17/2004 | EP1476190A1 Amino-substituted hypocrellins for use as sonosensitizers |
11/17/2004 | EP1476189A1 The use of tnf-alpha antagonist as drugs for the treatment of patients with sepsis and without suffering from total organ failure |
11/17/2004 | EP1476182A1 Immunogenic formulations of variable peptidic epitopes and process for preparation thereof |
11/17/2004 | EP1476181A2 Polyalkylene polymer compounds and uses thereof |
11/17/2004 | EP1476180A2 Interleukin-2 mutants with reduced toxicity |
11/17/2004 | EP1476173A1 Outer membrane vesicles from gram negative bacteria and use as a vaccine |
11/17/2004 | EP1476169A1 Methods of inhibiting orthopoxvirus replication with nucleoside compounds |
11/17/2004 | EP1476165A1 Substituted pyrimidinones and pyrimidinthiones |
11/17/2004 | EP1476163A2 Method of treating hiv infection by preventing interaction of cd4 and gp120 |
11/17/2004 | EP1476159A2 Compositions and formulations of 9- nitrocamptothecin polymorphs and methods of use thereof |
11/17/2004 | EP1476158A1 Nicotinamide derivatives useful as pde4 inhibitors |
11/17/2004 | EP1476157A1 Nicotinamide derivatives useful as pde4 inhibitors |
11/17/2004 | EP1476131A2 Compositions and methods for delivery of skin cosmeceuticals |
11/17/2004 | EP1476019A1 Aqueous antiseptic based on bispyridiniumalkanes |
11/17/2004 | EP1476018A1 Immunostimulant compositions comprising aminoalkyl glucosaminide phosphates and saponins |
11/17/2004 | EP1390063B1 Pharmaceutical dosage form of amorphous nelfinavir mesylate |
11/17/2004 | EP1362045B1 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry |
11/17/2004 | EP1289980B1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides |
11/17/2004 | EP1252322B1 Herpes virus strains for gene therapy |
11/17/2004 | EP1242413B1 Substituted 1,3,4-oxadiazoles and a method of reducing tnf-alpha levels |
11/17/2004 | EP1165560B1 2-hydroxy methylcyclopro pylidenemethyl purines as antiviral agents |
11/17/2004 | EP1154803B1 Immobilized labeling compounds and methods |
11/17/2004 | EP1109809B1 Pyrroloquinolines for treatment of obesity |
11/17/2004 | EP1077931B1 Benzamide derivatives for the treatment of diseases mediated by cytokines |
11/17/2004 | EP1073469B1 Stable mitoxantron solutions |
11/17/2004 | EP0942928B1 Subunit respiratory syncytial virus vaccine preparation |
11/17/2004 | EP0919628B1 Process for producing high-molecular-weight compounds of phenolic compounds, etc. and use thereof |
11/17/2004 | EP0852502B1 Lantibiotic mutants and chimeras of enhanced stability and activity |
11/17/2004 | EP0726957B1 RECOMBINANT DNase B DERIVED FROM STREPTOCOCCUS PYOGENES |
11/17/2004 | EP0679160B1 Pyrimidine nucleotide precursors for treatment of inflammatory hepatitis |
11/17/2004 | EP0652972B1 Pseudo-half-knot rna formation by hybridization of antisense oligonucleotides to target rna's secondary structure |
11/17/2004 | CN1547580A CCR5 antagonists useful for treating aids |
11/17/2004 | CN1547485A 疫苗组合物 Vaccine compositions |
11/17/2004 | CN1547484A Pharmaceutical dosage form of amorphous nelfinavir mesylate |
11/17/2004 | CN1547482A Use of POLY-GLU,TYR and T cells treated therewith for neuroprotective therapy |
11/17/2004 | CN1547476A Use of ATAZANAVIR in HIV therapy |
11/17/2004 | CN1547472A Fused pyrimidines as d-alanyl-d-alanine ligase inhibitors |
11/17/2004 | CN1547464A Prolonged release bioadhesive therapeutic systems |
11/17/2004 | CN1547433A Pesticidal formulation |
11/17/2004 | CN1546658A Artificially recombinant H9N2 hypotype influenza virus and its uses |
11/17/2004 | CN1546526A Method for preparing IgY for SARS |
11/17/2004 | CN1546514A Nucleotide specific for escherichia coli 0141 O-antigen |
11/17/2004 | CN1546513A Nucleotide specific for escherichia coli 0151 O-antigen |
11/17/2004 | CN1546512A Nucleotide specific for escherichia coli 0156 O-antigen |
11/17/2004 | CN1546511A Nucleotide specific for escherichia coli 0159 O-antigen |
11/17/2004 | CN1546510A Nucleotide specific for shigella bodyii 10 O-antigen |
11/17/2004 | CN1546509A Nucleotide specific for escherichia coli 054 O-antigen |
11/17/2004 | CN1546508A Nucleotide specific for shigella bodyii 2 O-antigen |
11/17/2004 | CN1546504A Rosemary acid anhydride compound ,its preparation method and use for treatment and prevention of AIDS |
11/17/2004 | CN1546172A Hyper-immune serum for resisting SARS virus and its preparation |
11/17/2004 | CN1546170A Novel use of recombined human antalzyme atomizing solution and inhalant in resisting drug-fast bacteria in pharmacy |
11/17/2004 | CN1546167A Prescription for preventing and treating fin rot of turbot |
11/17/2004 | CN1546163A Chinese traditional medicinal compositon for treating lymph tuberculosis |
11/17/2004 | CN1546161A Chinese traditional medicine capsule for restoring the normal function of liver |
11/17/2004 | CN1546159A Hepatitis treating medicine and its preparing process |
11/17/2004 | CN1546149A Effervescence tablet of antiviral medicine and its preparation process |
11/17/2004 | CN1546148A Ointment for expelling the wind and cold, removing toxic substances, removing blood stasis and its preparation |
11/17/2004 | CN1546139A Specific medicine for eradicating condyloma acuminatum |
11/17/2004 | CN1546130A Fungus killing agent applied in pudendal skin |
11/17/2004 | CN1546122A Compound medical ointment for treating tinea on manus and pedes |
11/17/2004 | CN1546114A Chinese traditional medicine extracts and its preparation and application in pharmacy |
11/17/2004 | CN1546103A Liver benefiting Huangxuan Yigan Powder and its preparing process |
11/17/2004 | CN1546095A Preparing method of concentrated Shuanghuanglian oral liquid |
11/17/2004 | CN1546093A Medicine for preventing and treating deficiency-cold and its preparation |
11/17/2004 | CN1546082A Green chiretta injection for treating gastrointestinal disease of animal |
11/17/2004 | CN1546081A Medicinal composition for treating tuberculosis and its preparing process |
11/17/2004 | CN1546079A Chinese traditional drug pills capable of protecting liver, resisting hepatic fibrosis and expelling toxins |
11/17/2004 | CN1546074A Chinese herbal granule for treating viral myocarditis and its preparing process |
11/17/2004 | CN1546071A Medicine for treating piglet yellow dysentery or white dysentery and its preparation method |
11/17/2004 | CN1546069A Huoxiang Zhengqi liquid capsule and its preparation |
11/17/2004 | CN1546068A Modified technique for making zedoary turmeric oil and glucose injection |
11/17/2004 | CN1546064A Freeze dried microecologic preparation for preventing and treating gallinaceous white dysentery |
11/17/2004 | CN1546060A Arsenic compound recipe for treating tuberculosis and dermatopathy |
11/17/2004 | CN1546051A Application of general saponin of gen-seng fruit in the preparation process of myocarditis treating medicine |
11/17/2004 | CN1546049A Medicine for treating hepatitis and its preparing process |
11/17/2004 | CN1546046A Adefovir dipivoxil dispersing tablet and its preparation |